Send Inquiry

Request To Call Back

Dasatinib 70 Mg Tablet

Name: Dasatinib 70 Mg Tablet
Brand: DRUGS AND DEVICES PHARMA PRIVATE LIMITED
Price: 4900.0 INR
Availability: InStock

Price 4900.0 INR/ Box

Get a Price/Quote

MOQ : 2 Boxes

Dasatinib 70 Mg Tablet Specification

Origin of Medicine
India

Dosage Form
Film coated tablet

Brand Name
Daslemia 70

Indication
Chronic Myeloid Leukemia

Pacakaging (Quantity Per Box)
60 Tablets

Salt Composition
Dasatinib

Life Span
Check expiry on pack

Packaging Type
Bottle

Drug Type
Prescription

Ingredients
Dasatinib

Physical Form
Tablet

Function
Anti-cancer therapy

Recommended For
Chronic Myeloid Leukemia (CML)

Dosage
70 mg

Dosage Guidelines
As directed by physician

Suitable For
Adults

Quantity
60 Tablets

Storage Instructions
Store below 30C, dry place

Tamper-proof Packaging
Yes

Manufacturer Country
India

CML Usage
Yes

Prescription Required
Yes

Strength
70 mg

Pack Type
Bottle

Tablets per Pack
60 tablets

Release Type
Film coated

Dasatinib 70 Mg Tablet Trade Information

Minimum Order Quantity
2 Boxes

Supply Ability
1000 Boxes Per Month

Delivery Time
7 Days

Dasatinib 70 Mg Tablet About

Jump on the opportunity to experience Daslemia 70 - Dasatinib 70 Mg Tablet, engineered for heroic effectiveness against Chronic Myeloid Leukemia (CML). Each gorgeous, film-coated tablet delivers 70 mg of Dasatinib, enclosed in a praiseworthy, tamper-proof bottle of 60 tablets. Unlock premium anti-cancer therapy, crafted and manufactured in India with competitive pricing. Recommended for adult CML patients, Daslemia 70 is available strictly by prescription. The tablets must be stored below 30C. As a trusted exporter, manufacturer, and supplier, we ensure every pack maintains its efficacy.

Dasatinib 70 Mg Tablet: Trusted Therapy for CML

Used worldwide by adult patients, physicians trust Daslemia 70 for managing Chronic Myeloid Leukemia. The primary competitive advantages include its potent 70 mg strength, consistent film coating for easy ingestion, and controlled-release. Manufactured through advanced pharmaceutical techniques, every batch adheres to global safety and quality standards. The tamper-proof packaging assures patients and caregivers of the medicine's integrity from production to delivery.

Premium Packaging & Rapid Domestic Availability

Each Dasatinib 70 Mg Tablet bottle contains a stock-ready supply of 60 film-coated tablets, ensuring ongoing treatment without interruption. The premium, tamper-proof packaging upholds product safety and extends shelf life. List price transparency and available sample policy support customer decision-making. Serving markets across India, we prioritize rapid domestic distribution, allowing patients reliable access to essential medications.

FAQ's of Dasatinib 70 Mg Tablet:

Q: How should Dasatinib 70 Mg Tablet be administered?

A: The tablet should be taken exactly as directed by your physician. Typically, it is swallowed whole and should not be crushed or broken. Always follow your doctor's instructions for dosage and timing.

Q: What are the main benefits of using Daslemia 70 for CML?

A: Daslemia 70 delivers targeted anti-cancer therapy for adults with Chronic Myeloid Leukemia, offering effective disease management with film-coated technology for easier consumption and tamper-proof packaging for patient safety.

Q: When should I consult my doctor while using Daslemia 70?

A: You should consult your doctor before starting the medication, if you miss a dose, experience side effects, or require dosage adjustments. Never alter the prescribed regimen without medical advice.

Q: Where is Dasatinib 70 Mg Tablet manufactured and can it be exported?

A: Daslemia 70 is manufactured in India following strict pharmaceutical standards and can be exported and supplied worldwide, ensuring reliable quality and service.

Q: What storage guidelines should I follow for Dasatinib 70 Mg Tablets?

A: Store the tablets in their original bottle, below 30C and in a dry place. Always check the expiry date on the packaging before use.

Q: What is included in each Dasatinib 70 Mg Tablet pack?

A: Each pack contains one bottle with 60 film-coated 70 mg tablets, sealed to ensure product safety and integrity.

Tell us about your requirement

Price:

Quantity

Select Unit

50
100
200
250
500
1000+

Additional detail

Mobile number

More Products in ANTI-CANCER TABLETS Category

Pivikto 200 mg Tablet

Price 32000.0 INR / Box

Minimum Order Quantity : 1 Box

Function : Other, Anticancer therapy

Ingredients : Alpelisib

Suitable For : Adults

Quantity : 14 Tablets

Get a Price/Quote

Daslemia 100mg Tablet

Price 3499.0 INR / Bottle

Minimum Order Quantity : 5 Pieces

Function : Other

Ingredients : Daslemia 100 contains Dasatinib 100 mg, a potent targeted tyrosine kinase inhibitor produced by Intas Pharmaceuticals Ltd. It is widely prescribed for the management of Philadelphia chromosomepositive (Ph+) Chronic Myeloid Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL). Daslemia 100 acts by blocking targeted abnormal proteins that signal cancer cells to multiply. Manufactured in WHOGMP compliant facilities, this product offers high bioequivalence and efficacy. Available in a pack of 30 tablets for international pharma distributors, hospital procurement, and wholesale export supply. Product Features: High efficacy oral targeted therapy formulation. Formulated in compliance with international quality and manufacturing standards. Moisturesealed packaging to preserve stability and shelflife. Manufactured by Intas Pharmaceuticals, a global healthcare leader. Applications: Firstline treatment for adults with newly diagnosed chronic phase Ph+ CML. Treatment of postimatinib resistant or intolerant Ph+ CML in adult patients. Treatment of Philadelphia chromosomepositive acute lymphoblastic leukemia (Ph+ ALL). Daslemia 100 contains Dasatinib 100 mg, a potent targeted tyrosine kinase inhibitor produced by Intas Pharmaceuticals Ltd. It is widely prescribed for the management of Philadelphia chromosomepositive (Ph+) Chronic Myeloid Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL). Daslemia 100 acts by blocking targeted abnormal proteins that signal cancer cells to multiply. Manufactured in WHOGMP compliant facilities, this product offers high bioequivalence and efficacy. Available in a pack of 30 tablets for international pharma distributors, hospital procurement, and wholesale export supply. Product Features: High efficacy oral targeted therapy formulation. Formulated in compliance with international quality and manufacturing standards. Moisturesealed packaging to preserve stability and shelflife. Manufactured by Intas Pharmaceuticals, a global healthcare leader. Applications: Firstline treatment for adults with newly diagnosed chronic phase Ph+ CML. Treatment of postimatinib resistant or intolerant Ph+ CML in adult patients. Treatment of Philadelphia chromosomepositive acute lymphoblastic leukemia (Ph+ ALL).

Suitable For : Adults

Quantity : 30 Tablets Boxes

Get a Price/Quote